Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Neurology|March 23, 2011
Long-term results of stem cell transplantation for MS: a single-center experienceA Fassas, V K Kimiskidis, I Sakellari, et al.Seminars in Hematology|August 7, 2001
Thalidomide in the management of multiple myelomaB Barlogie, M Zangari, T Spencer, et al.Bone Marrow Transplantation|September 26, 2001
Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapyA Fassas, I Gojo, A Rapoport, et al.Bone Marrow Transplantation|January 7, 1998
High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow TransplantationJ W Sweetenham, G Taghipour, D Milligan, et al.Journal of Neuroimmunology|May 15, 2007
Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapiesR Gold, A Jawad, D H Miller, et al.Journal of Clinical Immunology|May 8, 2000
Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacyA Fassas, A Anagnostopoulos, A Kazis, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2007
Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcomeVk Kimiskidis, I Sakellari, V Tsimourtou, et al.Bone Marrow Transplantation|March 15, 2006
Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patientsM H Miceli, L Dong, M L Grazziutti, et al.British Journal of Haematology|November 25, 1998
Anti-myeloma activity of pamidronate in vivoM V Dhodapkar, J Singh, J Mehta, et al.Bone Marrow Transplantation|February 26, 1999
Lymphomatoid granulomatosis following autologous stem cell transplantationA Fassas, S Jagannath, K R Desikan, et al.Pageof 6